Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling. - Berwick, Daniel C.; Javaheri, Behzad; Wetzel, Andrea; Hopkinson, Mark; Nixon-Abell, Jonathon; Grannò, Simone; Pitsillides, Andrew A.; Harvey, Kirsten (Molecular Neurodegeneration, 2017)